References

'References

'References

I. 2004. BCG vaccine. WHO position paper. Wkly Epidemiol Rec 79:27.

2. Abel, B., N. Thieblemont, V. J. Quesniaux, N. Brown, J. Mpagi, K. Miyake, F. Bihl, and B. Ryffel. 2002. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 169:3155.

3. Adam, A., J. F. Petit, J. Wietzerbin-Falszpan, P. Sinay, D. W. Thomas, and E. Lederer. 1969. FEES Lett 4:87

4. Aderem, A., and D. M. Underhill. 1999. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593.

5. Alexander, W. S. 2002. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immuno/2:410.

6. Algood, H. M., J. Chan, and J. L. Flynn. 2003. Chemokines and tuberculosis. Cytokine Growth Factor Rev 14:467.

7. Algood, H. M., P. L. Lin, and J. L. Flynn. 2005. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis 41 Suppl3:S189.

8. Andersen, P., D. Askgaard, L. Ljungqvist, M. W. Bentzon, and I. Heron. 1991. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 59:1558.

9. Andersen, P., D. Askgaard, L. Ljungqvist, J. Bennedsen, and I. Heron. 1991. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun 59:1905.

10. Andersen, P., D. Askgaard, A. Gottschau, J. Bennedsen, S. Nagai, and I. Heron. 1992. Identification of immunodominant antigens during infection with Mycobacterium tuberculosis. Scand J Immuno/36:823.

11. Andersen, P. 1994. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 62:2536.

12. Andersen, P. 1997. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol 45: lJ 5.

13. Andersen, P., and T. M. Doherty. 2005. TB subunit vaccines--putting the pieces together. Microbes Infect 7:911.

14. Andersen, P., and T. M. Doherty. 2005. The success and failure of BCG- implications for a novel tuberculosis vaccine. Nat Rev Microbial 3:656.

15. Anis, M. M., S. A. Fulton, S. M. Reba, C. V. Harding, and W. H. Boom. 2007. Modulation of naive CD4+ T-cell responses to an airway antigen during pulmonary mycobacterial infection. Infect Immun 75:2260.

163

References

16. Anis, M. M., S. A. Fulton, S.M. Reba, Y. Liu, C. V. Harding, and W. H. Boom. 2008. Modulation of pulmonary dendritic cell function during mycobacterial infection. Infect Immun 76:67I.

17. Apostolou, 1., Y. Takahama, C. Belmant, T. Kawano, M. Huerre, G. Marchal, J. Cui, M. Taniguchi, H. Nakauchi, J. J. Fournie, P. Kourilsky, and G. Gachelin. 1999. Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Nat! Acad Sci US A 96:5141.

18. Appelberg, R., I. M. Orme, M. I. Pinto de Sousa, and M. T. Silva. 1992. In vitro effects of interleukin-4 on interferon-gamma-induced macrophage activation. Immunology 76:553.

19. Appelberg, R. 2007. Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbio/15:87.

20. Argyrou, A., and J. S. Blanchard. 2001. Mycobacterium tuberculosis lipoamide dehydrogenase is encoded by Rv0462 and not by the lpdA or lpdB genes. Biochemist1y 40:11353.

21. Artis, D., L. M. Johnson, K. Joyce, C. Saris, A. Villarino, C. A. Hunter, and P. Scott. 2004. Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Thl cytokine responses following Leishmania major infection. J Immuno/172:4672.

22. Av-Gay, Y., and J. Davies. 1997. Components of eukaryotic-like protein signaling pathways in Mycobacterium tuberculosis. Microb. Camp. Genomics 2: 63.

23. Awomoyi, A. A., A. Marchant, J. M. Howson, K. P. McAdam, J. M. Blackwell, and M. J. Newport. 2002. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 186:1808.

24. Axelrod, S., H. Oschkinat, J. Enders, B. Schlegel, V. Brinkmann, S. H. Kaufmann, A. Haas, and U. E. Schaible. 2008. Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide. Cell Microbio/1 0:1530.

25. Bach, H., K. G. Papavinasasundaram, D. Wong, Z. Hmama, and Y. Av-Gay. 2008. Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 3:316.

26. Balcewicz-Sablinska, M. K., J. Keane, H. Kornfeld, and H. G. Remold. 1998. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation ofTNF-alpha. J Immuno/161:2636.

27. Balkhi, M. Y., A. Sinha, and K. Natarajan. 2004. Dominance of CD86, transforming growth factor- beta 1, and interleukin-10 in Mycobacterium tuberculosis secretory antigen-activated dendritic cells regulates T helper 1 responses to mycobacterial antigens. J Infect Dis 189:1598.

28. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.

29. Bannon, M. J. 1999. BCG and tuberculosis. Arch Dis Child 80:80.

30. Barnes, W. M. 1994. PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates. Proc Nat! Acad Sci US A 9I:2216.

31. Barra!, D. C., and M. B. Brenner. 2007. CDl antigen presentation: how it works. Nat Rev Immunol 7:929.

32. Basu, S., S. K. Pathak, A. Banerjee, S. Pathak, A. Bhattacharyya, Z. Yang, S. Talarico, M. Kundu, and J. Basu. 2007. Execution of macrophage apoptosis by PE_PGRS33 of Mycobacterium

164

'References

tuberculosis is mediated by Toll-like receptor 2-dependent release of tumor necrosis factor-alpha. J Bioi Chern 282:I039.

33. Beamer, G. L., D. K. Flaherty, B. D. Assogba, P. Stromberg, M. Gonzalez-Juarrero, R. de Waal Malefyt, B. Vesosky, and J. Turner. 2008. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. J Immunol18I:5545.

34. Beatty, W. L., and D. G. Russell. 2000. Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages. Infect Jmmun 68:6997.

35. Beatty, W. L., E. R. Rhoades, H. J. Ullrich, D. Chatterjee, J. E. Heuser, and D. G. Russell. 2000. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1:235.

36. Beetz, S., D. Wesch, L. Marischen, S. Welte, H. H. Oberg, and D. Kabelitz. 2008. Innate immune functions of human gammadelta T cells. 1mmunobiology 213: I 7 3.

37. Behr, M.A., M.A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P.M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520.

38. Behr, M. A. 2002. BCG--different strains, different vaccines? Lancet Infect Dis 2:86.

39. Belisle, J. T., V. D. Vissa, T. Sievert, K. Takayama, P. J. Brennan, and G. S. Besra. 1997. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276:1420.

40. Bermudez, L. E., and J. Goodman. 1996. Mycobacterium tuberculosis invades and replicates within type II alveolar cells.1nfect Jmmun 64:I400.

41. Bhatt, K., and P. Salgame. 2007. Host innate immune response to Mycobacterium tuberculosis. J Clin lmmunol 27:347.

42. Bloom, B. R., and W. R. Jacobs, Jr. 1989. New strategies for leprosy and tuberculosis and for development of bacillus Calmette-Guerin into a multi vaccine vehicle. Ann NY A cad Sci 569: I 55.

43. Blythe, M. J., Q. Zhang, K. Vaughan, R. de Castro, Jr., N. Salimi, H. H. Bui, D. M. Lewinsohn, J. D. Ernst, B. Peters, and A. Sette. 2007. An analysis of the epitope knowledge related to Mycobacteria.1mmunome Res 3:IO.

44. Boesen, H., B. N. Jensen, T. Wilcke, and P. Andersen. 1995. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun 63:149 I.

45. Boselli, D., G. Losana, P. Bernabei, D. Bosisio, P. Drysdale, R. Kiessling, J. S. Gaston, D. Lammas, J. L. Casanova, D. S. Kumararatne, and F. Novelli. 2007. lFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions. Eur J Immunol 3 7:2196.

46. Bosio, C. M., D. Gardner, and K. L. Elkins. 2000. Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology. J lmmuno/164:6417.

47. Bothamley, G. H. 1995. Serological diagnosis oftuberculosis. Eur RespirJ Suppl20:676s.

48. Boussiotis, V. A., E. Y. Tsai, E. J. Yunis, S. Thim, J. C. Delgado, C. C. Dascher, A. Berezovskaya, D. Rousset, J. M. Reynes, and A. E. Goldfeld. 2000. IL-l 0-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105:1317.

49. Brandt, L., T. Oettinger, A. Holm, A. B. Andersen, and P. Andersen. 1996. Key epitopes on the ESA T -6 antigen recognized in mice during the recall of protective immunity to Mycobacterium

165

References

tuberculosis. J Immuno/157:3527.

50. Brandt, L., M. Elhay, I. Rosenkrands, E. B. Lindblad, and P. Andersen. 2000. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 68:791.

51. Brandt, L., J. Feino Cunha, A. Weinreich Olsen, B. Chilima, P. Hirsch, R. Appelberg, and P. Andersen. 2002. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70:672.

52. Brennan, M. J., and G. Delogu. 2002. The PE multigene family: a 'molecular mantra' for mycobacteria. Trends Microbio/10:246.

53. Brennan, P. J. and P. Draper. 1994. Tuberculosis: Pathogenesis, Protection, and Control(ed. Bloom, B. R.)(Am. Soc. Microbiol., Washington DC).271.

54. Brewer, T. F. 2000. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta­analysis of the literature. Clin Infect Dis 31 Suppl 3:S64.

55. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732.

56. Brombacher, F., R. A. Kastelein, and G. Alber. 2003. Novel IL-12 family members shed light on the orchestration ofThl responses. Trend~Jmmuno/24:207.

57. Brookes, R. H., A. A. Pathan, H. McShane, M. Hensmann, D. A. Price, and A. V. Hill. 2003. CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages. Eur J Immunol 33:3293.

58. Brosch, R., S. V. Gordon, A. Billault, T. Gamier, K. Eiglmeier, C. Soravito, B. G. Barrell, and S. T. Cole. 1998. Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics. Infect Immun 66:222I.

59. Brosch, R., S. V. Gordon, M. Marmiesse, P. Brodin, C. Buchrieser, K. Eiglmeier, T. Gamier, C. Gutierrez, G. Hewinson, K. Kremer, L. M. Parsons, A. S. Pym, S. Samper, D. van Soolingen, and S. T. Cole. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Nat! Acad Sci US A 99:3684.

60. Buchmeier, N., and R. C. Fahey. 2006. The mshA gene encoding the glycosyltransferase of mycothiol biosynthesis is essential in Mycobacterium tuberculosis Erdman. FEMS Microbial Lett 264:74.

61. Buchmeier, N. A., G. L. Newton, and R. C. Fahey. 2006. A mycothiol synthase mutant of Mycobacterium tuberculosis has an altered thiol-disulfide content and limited tolerance to stress. J Bacterio/188:6245.

62. Bulut, Y., E. Faure, L. Thomas, 0. Equils, and M. Arditi. 2001. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-l receptor signaling molecules in Toll-like receptor 2 signaling. J Immuno/167:987.

63. Bunch-Christensen, K., A. Ladefoged, and J. Guld. 1968. The virulence of some strains of BCG for golden hamsters. Bull World Health Organ 39:821.

64. Byrd, S. R., R. Gelber, and L. E. Bermudez. 1993. Roles of soluble fibronectin and beta 1 integrin receptors in the binding of Mycobacterium leprae to nasal epithelial cells. Clin Immunol

166

'References

Immunopathol 69:266.

65. Canaday, D. H., C. Ziebold, E. H. Noss, K. A. Chervenak, C. V. Harding, and W. H. Boom. 1999. Activation of human CDS+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immuno/162:372.

66. Canaday, D. H., R. J. Wilkinson, Q. Li, C. V. Harding, R. F. Silver, and W. H. Boom. 2001. CD4(+) and CDS(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immuno/167:2734.

67. Caparros, E., P. Munoz, E. Sierra-Filardi, D. Serrano-Gomez, A. Puig-Kroger, J. L. Rodriguez­Fernandez, M. Mellado, J. Sancho, M. Zubiaur, and A. L. Corbi. 2006. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 107:3950.

6S. Cardona, P. J., A. Cooper, M. Luquin, A. Ariza, F. Filipo, I. M. Orme, and V. Ausina. 1999. The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand J Immunol 49:362.

69. Caruso, A. M., N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 162:5407.

70. Castro, A. G., R. A. Silva, and R. Appelberg. 1995. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. J Immunol 155:2013.

71. Chackerian, A. A., T. V. Perera, and S. M. Behar. 2001. Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis. Infect Immun 69:2666.

72. Chackerian, A., J. Alt, V. Perera, and S. M. Behar. 2002. Activation of NKT cells protects mice from tuberculosis. Infect Immun 70:6302.

73. Chackerian, A. A., J. M. Alt, T.V. Perera, C. C. Dascher, and S.M. Behar. 2002. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-ee!! immunity. Infect Immun 70:4501.

74. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 175:1111.

75. Chan, J., and J. L. Flynn. 1999. Nitric oxide in Mycobacterium tuberculosis infection. In Nitric Oxide and Infection, ed. F Fang, New York: Plenum : 2 81.

76. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 63:736.

77. Chen, Z. W. 2005. Immune regulation of gammadelta T cell responses in mycobacterial infections. Clin Immunol 116:202.

7S. Cheng, S., C. Fockler, W. M. Barnes, and R. Higuchi. 1994. Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Nat! Acad Sci US A 91:5695.

79. Choi, H. S., P. R. Rai, H. W. Chu, C. Cool, and E. D. Chan. 2002. Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. Am J Respir Crit Care Med 166:178.

167

References

80. Chua, J., and V. Deretic. 2004. Mycobacterium tuberculosis reprograms waves of phosphatidylinositol3-phosphate on phagosomal organelles. J Bioi Chern 279:36982.

81. Clemens, D. L., and M. A. Horwitz. 1996. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med 184:1349.

82. Colditz, G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. Jama 271:698.

83. Colditz, G. A., C. S. Berkey, F. Mosteller, T. F. Brewer, M. E. Wilson, E. Burdick, and H. V. Fineberg. 1995. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96:29.

84. Cole, S. T., R. Brosch, J. Parkhill, T. Gamier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry, 3rd, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M. A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, K. Taylor, S. Whitehead, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537.

85. Comas, I., and S. Gagneux. 2009. The past and future of tuberculosis research. PLoS Pathog 5:e1 000600.

86. Comstock, G. W. 1994. Field trials of tuberculosis vaccines: how could we have done them better? Control Clin Trials 15:247.

87. Condos, R., W. N. Rom, Y. M. Liu, and N. W. Schluger. 1998. Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med 157:729.

88. Cooper, A. M., L. B. Adams, D. K. Dalton, R. Appelberg, and S. Ehlers. 2002. IFN-gamma and NO in mycobacterial disease: new jobs for old hands. Trends Microbial 10:221.

89. Cooper, A. M., A. Kipnis, J. Turner, J. Magram, J. Ferrante, and I. M. Orme. 2002. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 168:1322.

90. Cooper, A.M. 2009. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol27:393.

91. Cowley, S.C., and K. L. Elkins. 2003. CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo. J Immunol 171:4689.

92. D'Souza, C. D., A. M. Cooper, A. A. Frank, S. Ehlers, J. Turner, A. Bendelac, and I. M. Orme. 2000. A novel nonclassic beta2-microglobulin-restricted mechanism influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung. Am J Respir Cell Mol Bioi 23:188.

93. Dahl, K. E., H. Shiratsuchi, B. D. Hamilton, J. J. Ellner, and Z. Toossi. 1996. Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun 64:399.

94. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739.

95. Dannenberg, A. M., Jr. 1993. Immunopathogenesis of pulmonary tuberculosis. Hasp Pract (Off

168

'References

Ed) 28:51.

96. Dannenberg, A.M., Jr., and F. M. Collins. 2001. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis (Edinb) 81:229.

97. Darrah, P. A., D. T. Patel, P.M. DeLuca, R. W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, M. Roederer, and R. A. Seder. 2007. Multifunctional THI cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13:843.

98. Darwin, K. H., S. Ehrt, J. C. Gutierrez-Ramos, N. Weich, and C. F. Nathan. 2003. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302:1963.

99. Davidsen, J., I. Rosenkrands, D. Christensen, A. Vangala, D. Kirby, Y. Perrie, E. M. Agger, and P. Andersen. 2005. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses. Biochim Biophys Acta 1718:22.

100. Davis, J. M., and L. Ramakrishnan. 2009. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 13 6:3 7.

101. de Jonge, M. 1., G. Pehau-Amaudet, M. M. Fretz, F. Romain, D. Bottai, P. Brodin, N. Honore, G. Marchal, W. Jiskoot, P. England, S. T. Cole, and R. Brosch. 2007. ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacterio/189:6028.

102. de Ia Barrera, S., M. Aleman, R. Musella, P. Schierloh, V. Pasquinelli, V. Garcia, E. Abbate, and C. Sasiain Mdel. 2004. IL-l 0 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CDS CTL in tuberculosis patients. Clin Exp Immuno/138: 128.

103. Deghmane, A. E., H. Soualhine, H. Bach, K. Sendide, S. Itoh, A. Tam, S. Noubir, A. Talal, R. Lo, S. Toyoshima, Y. Av-Gay, and Z. Hmama. 2007. Lipoamide dehydrogenase mediates retention of coronin-1 on BCG vacuoles, leading to arrest in phagosome maturation. J Cell Sci 120:2796.

104. Delogu, G., A. Li, C. Repique, F. Collins, and S. L. Morris. 2002. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin­conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis. Infect Immun 70:292.

105. Demangel, C., A. G. Bean, E. Martin, C. G. Feng, A. T. Kamath, and W. J. Britton. 1999. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guerin-infected dendritic cells. Eur J Jmmunol 29:1972.

106. Demangel, C., T. Gamier, I. Rosenkrands, and S. T. Cole. 2005. Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect Immun 73:2190.

107. Deretic, V., S. Singh, S. Master, J. Harris, E. Roberts, G. Kyei, A. Davis, S. de Haro, J. Naylor, H. H. Lee, and I. Vergne. 2006. Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbial 8:719.

108. Deuskar, N. J., and M. G. Deo. 1991. Mycobacterial cell surface proteins revealed by labeling with 125I.Jnt J Lepr Other Mycobact Dis 59:482.

109. Dheda, K., H. Booth, J. F. Huggett, M. A. Johnson, A. Zumla, and G. A. Rook. 2005. Lung remodeling in pulmonary tuberculosis. J Infect Dis 192:1201.

169

References

II 0. Dheenadhayalan, V., G. Delogu, and M. J. Brennan. 2006. Expression of the PE _pGRS 33 protein in Mycobacterium smegmatis triggers necrosis in macrophages and enhanced mycobacterial survival. Microbes Infect 8:262.

III. Dietrich, J., C. Aagaard, R. Leah, A. W. Olsen, A. Stryhn, T. M. Doherty, and P. Andersen. 2005. Exchanging ESA T6 with TB I 0.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immuno/174:6332.

112. Dietrich, J., C. Andersen, R. Rappuoli, T. M. Doherty, C. G. Jensen, and P. Andersen. 2006. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immuno/177:6353.

113. DiGiuseppe Champion, P. A., and J. S. Cox. 2007. Protein secretion systems in Mycobacteria. Cell Microbio/9:1376.

114. Dudani, R., K. Murali-Krishna, L. Krishnan, and S. Sad. 2008. IFN-gamma induces the erosion of preexisting CD8 T cell memory during infection with a heterologous intracellular bacterium. J Immunoi18I:1700.

115. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. Jama 282:677.

116. Edwards, K. M., M. H. Cynamon, R. K. Voladri, C. C. Hager, M.S. DeStefano, K. T. Tham, D. L. Lakey, M. R. Bochan, and D. S. Kernodle. 2001. lron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am J Respir Crit Care Med 164:2213.

117. Elhay, M. J., T. Oettinger, and P. Andersen. 1998. Delayed-type hypersensitivity responses to ESA T -6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect Immun 66:3454.

II8. Elias, D., H. Akuffo, A. Pawlowski, M. Haile, T. Schon, and S. Britton. 2005. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine 23:1326.

119. Elsen, S., J. Doussiere, C. L. Villiers, M. Faure, R. Berthier, A. Papaioannou, N. Grandvaux, P. N. Marche, and P. V. Vignais. 2004. Cryptic 02- -generating NADPH oxidase in dendritic cells. J Cell Sci 117:2215.

120. Engele, M., E. Stossel, K. Castiglione, N. Schwerdtner, M. Wagner, P. Bolcskei, M. Rollinghoff, and S. Stenger. 2002. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J Immuno/168: 1328.

121. Ernst, J.D. I998. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 66:1277.

122. Fang, F. C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide­related antimicrobial activity. J Clin Invest 99:2818.

123. Feng, C. G., M. Kaviratne, A. G. Rothfuchs, A. Cheever, S. Hieny, H. A. Young, T. A. Wynn, and A. Sher. 2006. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol 177:7086.

124. Fenton, M. J., and D. T. Golenbock. 1998. LPS-binding proteins and receptors. J Leukoc Bioi 64:25.

125. Ferrari, G., H. Langen, M. Naito, and J. Pieters. 1999. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cel/97:435.

170

'References

126. Ferrero, E., P. Biswas, K. Vettoretto, M. Ferrarini, M. Uguccioni, L. Piali, B. E. Leone, B. Moser, C. Rugarli, and R. Pardi. 2003. Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gammadelta cells. Immunology I08:365.

127. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339.

128. Flynn, J. L., M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom. 1992. Major histocompatibility complex class !-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Nat! A cad Sci US A 89: I 20 I 3.

129. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med I 78:2249.

130. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol I 55:25I 5.

131. Flynn, J. L., C. A. Scanga, K. E. Tanaka, and J. Chan. 1998. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 160:1796.

132. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu Rev 1mmunol19:93.

133. Flynn, J. L., and J. Chan. 2005. What's good for the host is good for the bug. Trends Microbial 13:98.

134. F ogan, L. 1969. PPD antigens and the diagnosis of mycobacterial diseases. A study of atypical mycobacterial disease in Oklahoma. Arch Intern Med 124:49.

135. Foote, S. 1999. Mediating immunity to mycobacteria. Nat Genet 21:345.

136. Fratti, R. A., J. M. Backer, J. Gruenberg, S. Corvera, and V. Deretic. 2001. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Bio/154:631.

137. Fratti, R. A., J. Chua, I. Vergne, and V. Deretic. 2003. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Nat! Acad Sci US A 100:5437.

138. Frieden, T. R., and S. S. Munsiff. 2005. The DOTS strategy for controlling the global tuberculosis epidemic. Clin Chest Med 26:197.

139. Fulton, S. A., J. V. Cross, Z. T. Toossi, and W. H. Boom. 1998. Regulation ofinterleukin-12 by interleukin-1 0, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon­gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. J Infect Dis 178:1l05.

140. Gallegos, A.M., E. G. Pamer, and M.S. Glickman. 2008. Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J Exp Med 205:2359.

141. Gansert, J. L., V. Kiessler, M. Engele, F. Wittke, M. Rollinghoff, A.M. Krensky, S. A. Porcelli, R. L. Modlin, and S. Stenger. 2003. Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immuno/170:3154.

142. Garg, A., P. F. Barnes, A. Porgador, S. Roy, S. Wu, J. S. Nanda, D. E. Griffith, W. M. Girard, N. Rawal, S. Shetty, and R. Vankayalapati. 2006. Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. J Immunol

171

'References

I77:6I92.

143. Garg, A., P. F. Barnes, S. Roy, M. F. Quiroga, S. Wu, V. E. Garcia, S. R. Krutzik, S. E. Weis, and R. Vankayalapati. 2008. Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol 38:459.

144. Gaynor, C. D., F. X. McCormack, D. R. Voelker, S. E. McGowan, and L. S. Schlesinger. 1995. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunoli55:5343.

145. Gehring, A. J., R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom. 2003. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fe gamma Rl on human macrophages through Toll-like receptor 2. Infect Immun 7I:4487.

146. Gehring, A. J., K. M. Dobos, J. T. Belisle, C. V. Harding, and W. H. Boom. 2004. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J Immuno/173:2660.

147. Geijtenbeek, T. B., S. J. Van Vliet, E. A. Koppel, M. Sanchez-Hernandez, C. M. Vandenbroucke­Grauls, B. Appelmelk, and Y. Van Kooyk. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med I97:7.

148. Gerosa, F., C. Nisii, S. Righetti, R. Micciolo, M. Marchesini, A. Cazzadori, and G. Trinchieri. 1999. CD4( +) T cell clones producing both interferon-gamma and interleukin- I 0 predominate in bronchoaiveolar lavages of active pulmonary tuberculosis patients. Clin Immunol 92:224.

I 49. Ghosh, S., and R. K. Saxena. 2004. Early effect of Mycobacterium tuberculosis infection on Mac-1 and !CAM-I expression on mouse peritoneal macrophages. Exp Mol Med 36:387.

!50. Giacomini, E., E. lona, L. Ferroni, M. Miettinen, L. Fattorini, G. Orefici, I. Julkunen, and E. M. Coccia. 2001. Infection of hum·an macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immuno!I66:7033.

I51. Gilleron, M., N. Himoudi, 0. Adam, P. Constant, A. Venisse, M. Riviere, and G. Puzo. 1997. Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans. Structure and localization of alkali-labile and alkali-stable phosphoinositides. J Bioi Chern 272:II7.

152. Gomes, M. S., and R. Appelberg. 2002. NRAMP1- or cytokine-induced bacteriostasis of Mycobacterium avium by mouse macrophages is independent of the respiratory burst. Microbiology I48:3I55.

I53. Gonzalez-Juarrero, M., and I. M. Orme. 2001. Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect Immun 69: II27.

154. Gonzalez-Juarrero, M., 0. C. Turner, J. Turner, P. Marietta, J. V. Brooks, and I. M. Orme. 2001. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect Immun 69: I722.

I 55. Griffin, J. P ., and I. M. Orme. I 994. Evolution of CD4 T -cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis. Infect Immun 62:I683.

156. Grode, L., P. Seiler, S. Baumann, J. Hess, V. Brinkmann, A. Nasser Eddine, P. Mann, C. Goosmann, S. Bandermann, D. Smith, G. J. Bancroft, J. M. Reyrat, D. van Soolingen, B. Raupach, and S. H. Kaufmann. 2005. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest

172

References

115:2472.

157. Guinn, K. M., M. J. Hickey, S. K. Mathur, K. L. Zakel, 1. E. Grotzke, D. M. Lewinsohn, S. Smith, and D. R. Sherman. 2004. Individual RDI-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbio/51:359.

158. Gutierrez, M.G., S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. Deretic. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cellll9:753.

159. Haga, S., R. Yamaguchi, S. Nagai, K. Matsuo, A. Yamazaki, and R. M. Nakamura. 1995. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized to Mycobacterium tuberculosis or Mycobacterium bovis BCG. J Leukoc Bioi 57:221.

160. Hajjar, A.M., D. S. O'Mahony, A. Ozinsky, D. M. Underhill, A. Aderem, S. J. Klebanoff, and C. B. Wilson. 2001. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLRI or TLR6 in response to phenol-soluble modulin. J Immuno/166: 15.

161. Harboe, M. 1981. Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis. Am Rev Respir Dis 124:80.

162. Harboe, M., T. Oettinger, H. G. Wiker, I. Rosenkrands, and P. Andersen. 1996. Evidence for occurrence of the ESA T -6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovisand for its absence in Mycobacterium bovis BCG. Infect Immun 64:16.

163. Harding, C. V., and W. H. Boom. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbial 8:296.

164. Haslov, K., A. Andersen, S. Nagai, A. Gottschau, T. Sorensen, and P. Andersen. 1995. Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun 63:804.

165. Hava, D. L., N. van der Wei, N. Cohen, C. C. Dascher, D. Houben, L. Leon, S. Agarwal, M. Sugita, M. van Zon, S. C. Kent, H. Shams, P. J. Peters, and M. B. Brenner. 2008. Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation. Proc Nat! Acad Sci US A 105:11281.

166. Havlir, D. V., R. S. Wallis, W. H. Boom, T. M. Daniel, K. Chervenak, and J. J. Ellner. 1991. Human immune response to Mycobacterium tuberculosis antigens. Infect Immun 59:665.

167. Havlir, D. V., and P. F. Barnes. 1999. Tuberculosis in patients with human immunodeficiency virus infection. N Eng! J Med 340:367.

168. Hemmi, H., 0. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740.

169. Henderson, R. A., S. C. Watkins, and J. L. Flynn. 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J lmmuno/159:635.

170. Hermans, P. W., D. van Soolingen, and J. D. van Embden. 1992. Characterization of a major polymorphic tandem repeat in Mycobacterium tuberculosis and its potential use in the epidemiology of Mycobacterium kansasii and Mycobacterium gordonae. J Bacteriol/74:4157.

171. Hemandez-Pando, R., H. Orozcoe, A. Sampieri, L. Pavon, C. Velasquillo, J. Larriva-Sahd, J. M. Alcocer, and M. V. Madrid. 1996. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tubercu!osis.lmmunology 89:26.

173

'References

172. Hess, J., U. Schaible, B. Raupach, and S. H. Kaufmann. 2000. Exploiting the immune system: toward new vaccines against intracellular bacteria. Adv Jmmunol 7 5:1.

173. Hickman, S. P., J. Chan, and P. Salgame. 2002. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J lmmunol 168:4636.

174. Hingley-Wilson, S.M., V. K. Sambandamurthy, and W. R. Jacobs, Jr. 2003. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat lmmuno/4:949.

175. Hirsch, C. S., J. J. Ellner, D. G. Russell, and E. A. Rich. 1994. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J lmmunol 152:743.

176. Hisert, K. B., M.A. Kirksey, J. E. Gomez, A. 0. Sousa, J. S. Cox, W. R. Jacobs, Jr., C. F. Nathan, and J. D. McKinney. 2004. Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening. Infect Immun 72:5315.

177. Hmama, Z., K. Sendide, A. Tala!, R. Garcia, K. Dobos, and N. E. Reiner. 2004. Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an lalpha,25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. J Cell Sci 117:2131.

178. Howard, A. D., and B. S. Zwilling. 1999. Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin Exp Immunol 115:428.

179. Hsu, T., S. M. Hingley-Wilson, B. Chen, M. Chen, A. Z. Dai, P.M. Morin, C. B. Marks, J. Padiyar, C. Goulding, M. Gingery, D. Eisenberg, R. G. Russell, S.C. Derrick, F. M. Collins, S. L. Morris, C. H. King, and W. R. Jacobs, Jr. 2003. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Nat! Acad Sci US A 100:12420.

180. Hubbard, R. D., C. M. Flory, and F. M. Collins. 1992. Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp lmmuno/87:94.

181. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev lmmunol 5:521.

182. lndrigo, J., R. L. Hunter, Jr., and J. K. Actor. 2003. Cord factor trehalose 6,6'-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 149:2049.

183. Jayachandran, R., V. Sundaramurthy, B. Combaluzier, P. Mueller, H. Korf, K. Huygen, T. Miyazaki, I. Albrecht, J. Massner, and J. Pieters. 2007. Survival of mycobacteria in macrophages is mediated by coronin !-dependent activation of calcineurin. Cell 130:37.

184. Jayawardena-Wolf, J., and A. Bendelac. 2001. CD 1 and lipid antigens: intracellular pathways for antigen presentation. Curr Opin 1mmunol 13:109.

185. Jiao, X., R. Lo-Man, P. Guermonprez, L. Fiette, E. Deriaud, S. Burgaud, B. Gicquel, N. Winter, and C. Leclerc. 2002. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J Immunol 168:1294.

186. Johnson, C. M., A.M. Cooper, A. A. Frank, C. B. Bonorino, L. J. Wysoki, and I. M. Orme. 1997. Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice. Tuber Lung Dis 78:257.

187. Jones, B. W., T. K. Means, K. A. Heldwein, M.A. Keen, P. J. Hill, J. T. Belisle, and M. J. Fenton.

174

'References

2001. Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Bioi 69:1036.

188. Jung, Y. J., L. Ryan, R. LaCourse, and R. J. North. 2003. Increased interleukin-10 expression is not responsible for failure ofT helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice. Immunology 109:295.

189. Jung, Y. 1., L. Ryan, R. LaCourse, and R. J. North. 2005. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J Exp Med 201:1915.

190. Kahnert, A., U. E. Hopken, M. Stein, S. Bandermann, M. Lipp, and S. H. Kaufmann. 2007. Mycobacterium tuberculosis triggers formation of lymphoid structure in murine lungs. J Infect Dis I95:46.

191. Kaisho, T., and S. Akira. 2000. Critical roles of Toll-like receptors in host defense. Crit Rev Immunol 20:393.

192. Kalinski, P., C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal.Immunol Today 20:561.

193. Kamath, A. B., J. Woodworth, X. Xiong, C. Taylor, Y. Weng, and S.M. Behar. 2004. Cytolytic CD8+ T cells recognizing CFPIO are recruited to the lung after Mycobacterium tuberculosis infection. J Exp Med 200:1479.

194. Kang, P. B., A. K. Azad, J. B. Torrelles, T. M. Kaufman, A. Beharka, E. Tibesar, L. E. DesJardin, and L. S. Schlesinger. 2005. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 202:987.

195. Kantengwa, S., L. Jornot, C. Devenoges, and L. P. Nicod. 2003. Superoxide anions induce the maturation of human dendritic cells. Am J Respir Crit Care Med 167:431.

196. Kaplan, G., F. A. Post, A. L. Moreira, H. Wainwright, B. N. Kreiswirth, M. Tanverdi, B. Mathema, S. V. Ramaswamy, G. Walther, L. M. Steyn, C. E. Barry, 3rd, and L. G. Bekker. 2003. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect 1mmun 71:7099.

197. Kariyone, A., K. Higuchi, S. Yamamoto, A. Nagasaka-Kametaka, M. Harada, A. Takahashi, N. Harada, K. Ogasawara, and K. Takatsu. 1999. Identification of amino acid residues of the T -cell epitope of Mycobacterium tuberculosis alpha antigen critical for Vbetall(+) Thl cells. Infect lmmun 67:4312.

198. Katti, M. K., G. Dai, L. Y. Armitige, C. Rivera Marrero, S. Daniel, C. R. Singh, D. R. Lindsey, S. Dhandayuthapani, R. L. Hunter, and C. Jagannath. 2008. The Delta tbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells. Cell Microbio/10:1286.

199. Kaufmann, S. H. Novel tuberculosis vaccination strategies based on understanding the immune response. J Intern Med 267:337.

200. Kaufmann, S. H. 2006. Tuberculosis: back on the immunologists' agenda. Immunity 24:351.

201. Keane, J., M. K. Balcewicz-Sablinska, H. G. Remold, G. L. Chupp, B. B. Meek, M. J. Fenton, and H. Kornfeld. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis.Infect Immun 65:298.

202. Khader, S. A., J. E. Pearl, K. Sakamoto, L. Gilmartin, G. K. Bell, D. M. Jelley-Gibbs, N. Ghilardi,

175

References

216. Lade], C. H., S. Daugelat, and S. H. Kaufmann. 1995. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and ll-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur J Immunol 25:377.

217. Ladel, C. H., C. Blum, A. Dreher, K. Reifenberg, M. Kopf, and S. H. Kaufmann. 1997. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 65:4843.

218. Lagranderie, M. R., A. M. Balazuc, E. Deriaud, C. D. Leclerc, and M. Gheorghiu. 1996. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect lmmun 64:1.

219. Latchumanan, V. K., B. Singh, P. Sharma, and K. Natarajan. 2002. Mycobacterium tuberculosis antigens induce the differentiation of dendritic cells from bone marrow. J Immunol169:6856.

220. Latchumanan, V. K., M. Y. Balkhi, A. Sinha, B. Singh, P. Sharma, and K. Natarajan. 2005. Regulation of immune responses to Mycobacterium tuberculosis secretory antigens by dendritic cells. Tuberculosis (Edinb) 85:377.

221. Law, K., M. Weiden, T. Harkin, K. Tchou-Wong, C. Chi, and W. N. Rom. 1996. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med !53: 799.

222. Lazarevic, V., D. Nolt, and J. L. Flynn. 2005. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J I mmunol 1 7 5:110 7.

223. Lederer, E., A. Adam, R. Ciorbaru, J. F. Petit, and J. Wietzerbin. 1975. Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Mol Cell Biochem 7:87.

224. Lee, J. S., R. Krause, J. Schreiber, H. J. Mollenkopf, J. Kowall, R. Stein, B. Y. Jeon, J. Y. Kwak, M. K. Song, J.P. Patron, S. Jorg, K. Rob, S. N. Cho, and S. H. Kaufmann. 2008. Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain. Cell Host Microbe 3:97.

225. Lefford, M. J. 1975. Transfer of adoptive immunity to tuberculosis m mice. Infect Immun 11:1174.

226. Lenaz, G. 2001. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52:159.

227. Levine, B., and D. J. Klionsky. 2004. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6:463.

228. Lewinsohn, D. A., E. Winata, G. M. Swarbrick, K. E. Tanner, M. S. Cook, M. D. Null, M. E. Cansler, A. Sette, J. Sidney, and D. M. Lewinsohn. 2007. lmmunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog 3:1240.

229. Li, X., K. K. McKinstry, S. L. Swain, and D. K. Dalton. 2007. IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J Immuno/179:939.

230. Liam, C. K., and B. G. Tang. 1997. Delay in the diagnosis and treatment of pulmonary tuberculosis in patients attending a university teaching hospital. Int J Tuberc Lung Dis 1:326.

231. Liang, Y., X. Wu, J. Zhang, N. Li, Q. Yu, Y. Yang, X. Bai, C. Liu, Y. Shi, Q. Liu, P. Zhang, and Z. Li. 2008. The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin. Vaccine 26:4536.

177

'References

232. Lin, P. L., S. Pawar, A. Myers, A. Pegu, C. Fuhrman, T. A. Reinhart, S. V. Capuano, E. Klein, and J. L. Flynn. 2006. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 74:3790.

233. Lingnau, K., K. Riedl, and A. von Gabain. 2007. IC31 and IC30, novel types of vaccine adjuvant based on peptide delivery systems. Expert Rev Vaccines 6:7 41.

234. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, D. L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zugel, R. L. Gallo, D. Eisenberg, M. Hewison, B. W. Hollis, J. S. Adams, B. R. Bloom, and R. L. Modlin. 2006. Toll­like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770.

235. Liu, P. T., S. Stenger, D. H. Tang, and R. L. Modlin. 2007. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol179:2060.

236. Locht, C., J. M. Hougardy, C. Rouanet, S. Place, and F. Mascart. 2006. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberculosis (Edinb) 86:303.

237. Lozes, E., K. Huygen, J. Content, 0. Denis, D. L. Montgomery, A. M. Yawman, P. Vandenbussche, J. P. Van Vooren, A. Drowart, J. B. Ulmer, and M. A. Liu. 1997. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15:830.

238. Lucey, D. R., M. Clerici, and G. M. Shearer. 1996. Type I and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbial Rev 9:532.

239. Lugosi, L. 1992. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guerin to molecular biology. A review. Tuber Lung Dis 73:252.

240. Lukacs, N. W., C. L. Addison, J. Gauldie, F. Graham, K. Simpson, R. M. Strieter, K. Warmington, S. W. Chensue, and S. L. Kunkel. 1997. Transgene-induced production of IL-4 alters the development and collagen expression ofT helper cell 1-type pulmonary granulomas. J Immunol 158:4478.

241. Lyashchenko, K., R. Colangeli, M. Houde, H. AI Jahdali, D. Menzies, and M. L. Gennaro. 1998. Heterogeneous antibody responses in tuberculosis. Infect Immun 66:3936.

242. MacGurn, J. A., and J. S. Cox. 2007. A genetic screen for Mycobacterium tuberculosis mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system. Infect Immun 75:2668.

243. Mack, U., G. B. Migliori, M. Sester, H. L. Rieder, S. Ehlers, D. Goletti, A. Bossink, K. Magdorf, C. Holscher, B. Kampmann, S.M. Arend, A. Detjen, G. Bothamley, J.P. Zellweger, H. Milburn, R. Die!, P. Ravn, F. Cobelens, P. J. Cardona, B. Kan, I. Solovic, R. Duarte, and D. M. Cirillo. 2009. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33:956.

244. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu Rev Jmmunoli5:323.

245. MacMicking, J.D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Nat/ Acad Sci US A 94:5243.

246. MacMicking, J.D., G. A. Taylor, and J.D. McKinney. 2003. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302:654.

178

References

247. Madebo, T., and B. Lindtjom. 1999. Delay in treatment ofpulmonary tuberculosis: an analysis of symptom duration among Ethiopian patients. Med. Gen. Med: £6

248. Maeda, N., J. Nigou, J. L. Herrmann, M. Jackson, A. Amara, P. H. Lagrange, G. Puzo, B. Gicquel, and 0. Neyrolles. 2003. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem 278:5513.

249. Maglione, P. J., J. Xu, and J. Chan. 2007. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J Jmmunol 178:7222.

250. Maglione, P. J., J. Xu, A. Casadevall, and J. Chan. 2008. Fe gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. J lmmunol 180:3329.

251. Maldonado-Lopez, R., C. Maliszewski, J. Urbain, and M. Moser. 2001. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Thl/Th2 cells in vivo. J Jmmuno/167:4345.

252. Malhotra, I., P. Mungai, A. Wamachi, J. Kioko, J. H. Ouma, J. W. Kazura, and C. L. King. 1999. Helminth- and Bacillus Calmette-Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J lmmuno/162:6843.

253. Malowany, J. I., S. McCormick, M. Santosuosso, X. Zhang, N. Aoki, P. Ngai, J. Wang, J. Leitch, J. Bramson, Y. Wan, and Z. Xing. 2006. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. Mol Ther 13:766.

254. Manabe, Y. C., and W. R. Bishai. 2000. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med 6:1327.

255. Manganelli, R., R. Provvedi, S. Rodrigue, J. Beaucher, L. Gaudreau, and I. Smith. 2004. Sigma factors and global gene regulation in Mycobacterium tuberculosis. J Bacterio/186:895.

256. Martin, C., A. Williams, R. Hemandez-Pando, P. J. Cardona, E. Gormley, Y. Bordat, C. Y. Soto, S. 0. Clark, G. J. Hatch, D. Aguilar, V. Ausina, and B. Gicquel. 2006. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs. Vaccine 24:3408.

257. Martineau, A. R., S.M. Newton, K. A. Wilkinson, B. Kampmann, B. M. Hall, N. Nawroly, G. E. Packe, R. N. Davidson, C. J. Griffiths, and R. J. Wilkinson. 2007. Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 117:1988.

258. Master, S. S., S. K. Rampini, A. S. Davis, C. Keller, S. Ehlers, B. Springer, G. S. Timmins, P. Sander, and V. Deretic. 2008. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 3:224.

259. Matsue, H., D. Edelbaum, D. Shalhevet, N. Mizumoto, C. Yang, M. E. Mummert, J. Oeda, H. Masayasu, and A. Takashima. 2003. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J 1mmunol 171:3010.

260. Mazzaccaro, R. J., M. Gedde, E. R. Jensen, H. M. van Santen, H. L. Ploegh, K. L. Rock, and B. R. Bloom. 1996. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Nat! A cad Sci US A 93:11786.

261. McKinney, J.D., K. Honer zu Bentrup, E. J. Munoz-Eiias, A. Miczak, B. Chen, W. T. Chan, D. Swenson, J. C. Sacchettini, W. R. Jacobs, Jr., and D. G. Russell. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme

179

'References

isocitrate lyase. Nature 406:735.

262. McPhail, L. C., S. L. Strum, P. A. Leone, and S. Sozzani. 1992. The neutrophil respiratory burst mechanism.Immunol Ser 57:47.

263. McShane, H., S. Behboudi, N. Goonetilleke, R. Brookes, and A. V. Hill. 2002. Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.Infect Immun 70:I623.

264. McShane, H., A. A. Pathan, C. R. Sander, S. M. Keating, S. C. Gilbert, K. Huygen, H. A. Fletcher, and A. V. Hill. 2004. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 10:1240.

265. Means, T. K., S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton. 1999. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol I63:3920.

266. Means, T. K., E. Lien, A. Yoshimura, S. Wang, D. T. Golenbock, and M. J. Fenton. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immuno/163:6748.

267. Medzhitov, R., and C. Janeway, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbial 8:452.

268. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat Rev Immuno/1: I35.

269. Menozzi, F. D., J. H. Rouse, M. Alavi, M. Laude-Sharp, J. Muller, R. Bischoff, M. J. Brennan, and C. Locht. 1996. Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med 184:993.

270. Metchnikoff, E. 1905.Immunity to Infective Disease. Cambridge: Cambridge University Press.

271. Milstien, J. B., and J. J. Gibson. 1990. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ 68:93.

272. Mohan, V. P., C. A. Scanga, K. Yu, H. M. Scott, K. E. Tanaka, E. Tsang, M. M. Tsai, J. L. Flynn, and J. Chan. 2001. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69:1847.

273. Molle, V., N. Saint, S. Campagna, L. Kremer, E. Lea, P. Draper, and G. Molle. 2006. pH­dependent pore-forming activity of OmpATb from Mycobacterium tuberculosis and characterization of the channel by peptidic dissection. Mol Microbio/61:826.

274. Moody, D. B., M. Sugita, P. J. Peters, M. B. Brenner, and S. A. Porcelli. 1996. The CDI-restricted T-ee!! response to mycobacteria. Res Immuno/147:550.

275. Mortellaro, A., L. Robinson, and P. Ricciardi-Castagnoli. 2009. Spotlight on Mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge? EMBO Mol Med 1:19.

276. Muller, I., S. P. Cobbold, H. Waldmann, and S. H. Kaufmann. 1987. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun 55:2037.

277. Munk, M. E., A. J. Gatrill, and S. H. Kaufmann. 1990. Target cell lysis and IL-2 secretion by gamma/delta T lymphocytes after activation with bacteria. J Immuno/145:2434.

278. Mustafa, A. S., H. A. Amoudy, H. G. Wiker, A. T. Abal, P. Ravn, F. Oftung, and P. Andersen. 1998. Comparison of antigen-specific T -cell responses of tuberculosis patients using complex or

180

References

single antigens of Mycobacterium tuberculosis. Scand J Immuno/48:535.

279. Natarajan, K., N. C. Sahoo, and K. V. Rao. 2001. Signal thresholds and modular synergy during expression of costimulatory molecules in B lymphocytes. J Immunol 167:114.

280. Natarajan, K., V. K. Latchumanan, B. Singh, S. Singh, and P. Sharma. 2003. Down-regulation of T helper 1 responses to mycobacterial antigens due to maturation of dendritic cells by 1 0-kDa mycobacterium tuberculosis secretory antigen. J Infect Dis 187:914.

281. Nathan, C., and M. U. Shiloh. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Nat! Acad Sci U S A 97:8841.

282. Newton, G. L., N. Buchmeier, and R. C. Fahey. 2008. Biosynthesis and functions of mycothiol, the unique protective thiol of Actinobacteria. Microbial Mol Bioi Rev 72:471.

283. Ng, V. H., J. S. Cox, A. 0. Sousa, J.D. MacMicking, and J.D. McKinney. 2004. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbio/52:1291.

284. Nicholson, S., G. Bonecini-Almeida Mda, J. R. Lapa e Silva, C. Nathan, Q. W. Xie, R. Mumford, J. R. Weidner, J. Calaycay, J. Geng, N. Boechat, C. Linhares, W. Rom, and J. L. Ho. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 183:2293.

285. Nigou, J., C. Zelle-Rieser, M. Gilleron, M. Thumher, and G. Puzo. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol 166:7 477.

286. North, R. J. 1973. Importance of thymus-derived lymphocytes in cell-mediated immunity to infection. Cell Immunol 7:166.

287. North, R. J. 1995. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J Infect Dis 172:1550.

288. North, R. J. 1998. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immuno/113:55.

289. Noss, E. H., C. V. Harding, and W. H. Boom. 2000. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell Immuno/201:63.

290. Noss, E. H., R. K. Pai, T. 1. Sellati, J.D. Radolf, J. Belisle, D. T. Golenbock, W. H. Boom, and C. V. Harding. 2001. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immuno/167:910.

291. Oddo, M., T. Renno, A. Attinger, T. Bakker, H. R. MacDonald, and P. R. Meylan. 1998. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 160:5448.

292. Oettinger, T., M. Jorgensen, A. Ladefoged, K. Haslov, and P. Andersen. 1999. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber Lung Dis 79:243.

293. Olsen, A. W., P. R. Hansen, A. Holm, and P. Andersen. 2000. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. EurJ 1mmunol30:1724.

181

'References

294. Olsen, A. W., A. Williams, L. M. Okkels, G. Hatch, and P. Andersen. 2004. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT -6 in the aerosol guinea pig mode!. Infect Immun 72:6148.

295. Orme, I. M., and F. M. Collins. 1984. Adoptive protection of the Mycobacterium tuberculosis­infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cel!Immunol 84:113.

296. Orme, I. M. 1987. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol 138:29 3.

297. Orme, I. M. 1988. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun 56:3310.

298. Orme, I. M., E. S. Miller, A. D. Roberts, S. K. Furney, J. P. Griffin, K. M. Dobos, D. Chi, B. Rivoire, and P. J. Brennan. 1992. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J Immunol 148:189.

299. Orme, I. M., P. Andersen, and W. H. Boom. 1993. T cell response to Mycobacterium tuberculosis. J Infect Dis 167:1481.

300. Orme, I. M. 2005. The use of animal models to guide rational vaccine design. Microbes Infect 7:905.

301. Orme, I. M. 2006. Preclinical testing of new vaccines for tuberculosis: a comprehensive review. Vaccine 24:2.

302. Othieno, C., C. S. Hirsch, B. D. Hamilton, K. Wilkinson, J. J. Ellner, and Z. Toossi. 1999. Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta! and interleukin-lO.Infect Immun 67:5730.

303. Othieno, C., C. S. Hirsch, B. D. Hamilton, K. Wilkinson, J. J. Ellner, and Z. Toossi. 1999. Interaction of Mycobacterium tuberculosis-induced transforming growth factor betal and interleukin-lO.Infect Immun 67:5730.

304. Ottenhoff, T. H., D. Kumararatne, and J. L. Casanova. 1998. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 19:491.

305. Ottenhoff, T. H. 2009. Overcoming the global crisis: "yes, we can", but also for TB ... ? Eur J Immuno/39:2014.

306. Ozinsky, A., D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Nat! Acad Sci U SA 97:13766.

307. Pacheco, A. G., C. C. Cardoso, and M. 0. Moraes. 2008. IFNG +874T/A, ILIO -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. Hum Genet 123:477.

308. Pai, R. K., M. Convery, T. A. Hamilton, W. H. Boom, and C. V. Harding. 2003. Inhibition ofiFN­gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immuno/171: 175.

309. Pai, R. K., M. E. Pennini, A. A. Tobian, D. H. Canaday, W. H. Boom, and C. V. Harding. 2004.

182

'References

Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.Infect Immun 72:6603.

310. Pais, T. F., R. A. Silva, B. Smedegaard, R. Appelberg, and P. Andersen. 1998. Analysis ofT cells recruited during delayed-type hypersensitivity to purified protein derivative (PPD) versus challenge with tuberculosis infection. Immunology 95:69.

311. Pal, P. G., and M. A. Horwitz. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 60:4781.

312. Pandey, A. K., and C. M. Sassetti. 2008. Mycobacterial persistence requires the utilization ofhost cholesterol. Proc Nat! Acad Sci US A 105:4376.

313. Pasula, R., J. R. Wright, D. L. Kachel, and W. J. Martin, 2nd. 1999. Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J Clin Invest 103:483.

314. Pearl, J. E., B. Saunders, S. Ehlers, I. M. Orme, and A. M. Cooper. 2001. Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse. Celllmmunol 211:43.

315. Pearl, J. E., S. A. Khader, A. Solache, L. Gilmartin, N. Ghilardi, F. deSauvage, and A.M. Cooper. 2004. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immuno/173:7490.

316. Pecora, N. D., A. J. Gehring, D. H. Canaday, W. H. Boom, and C. V. Harding. 2006. Mycobacterium tuberculosis LprA is a lipoprotein agonist ofTLR2 that regulates innate immunity and APC function. J lmmunol 177:422.

317. Pecora, N.D., S. A. Fulton, S.M. Reba, M.G. Drage, D.P. Simmons, N.J. Urankar-Nagy, W. H. Boom, and C. V. Harding. 2009. Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection. Celllmmunol 254:94.

318. Pennini, M. E., R. K. Pai, D. C. Schultz, W. H. Boom, and C. V. Harding. 2006. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits lFN-gamma-induced chromatin remodeling of MHC2T A by TLR2 and MAPK signaling. J Immunol I76:4323.

319. Pethe, K., D. L. Swenson, S. Alonso, J. Anderson, C. Wang, and D. G. Russell. 2004. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc Nat! AcadSciUSA 101:13642.

320. Philips, J. A., M. C. Porto, H. Wang, E. J. Rubin, and N. Perrimon. 2008. ESCRT factors restrict mycobacterial growth. Proc Nat! Acad Sci US A 105:3070.

321. Piddington, D. L., F. C. Fang, T. Laessig, A.M. Cooper, I. M. Orme, and N. A. Buchmeier. 2001. Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect Immun 69:4980.

322. Pollock, J. M., and P. Andersen. 1997. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis oftuberculosis. J Infect Dis 175:1251.

323. Poulet, S., and S. T. Cole. 1995. Characterization of the highly abundant polymorphic GC-rich­repetitive sequence (PGRS) present in Mycobacterium tuberculosis. Arch Microbio/163:87.

324. Prigozy, T. I., P. A. Sieling, D. Clemens, P. L. Stewart, S. M. Behar, S. A. Porcelli, M. B. Brenner, R. L. Modlin, and M. Kronenberg. 1997. The mannose receptor delivers lipoglycan

183

'References

antigens to endosomes for presentation to T cells by CD 1 b molecules. Immunity 6:187.

325. Purdy, G. E., R. M. Owens, L. Bennett, D. G. Russell, and B. A. Butcher. 2005. Kinetics of phosphatidylinositol-3-phosphate acquisition differ between IgG bead-containing phagosomes and Mycobacterium tuberculosis-containing phagosomes. Cell Microbial 7:162 7.

326. Quesniaux, V. J., D. M. Nicolle, D. Torres, L. Kremer, Y. Guerardel, J. Nigou, G. Puzo, F. Erard, and B. Ryffel. 2004. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent­negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 172:4425.

327. Quinn, T. C. 1989. Interactions of the human immunodeficiency virus and tuberculosis and the implications for BCG vaccination. Rev Infect Dis 11 Suppl 2:S379.

328. Radosevic, K., C. W. Wieland, A. Rodriguez, G. J. Weverling, R. Mintardjo, G. Gillissen, R. Vogels, Y. A. Skeiky, D. M. Hone, J. C. Sadoff, T. van der Poll, M. Havenga, and J. Goudsmit. 2007. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CDS T-cell epitope mapping and role of gamma interferon. Infect Immun 75:4105.

329. Ramakrishnan, L., N. A. Federspiel, and S. Falkow. 2000. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288:1436.

330. Ratledge, C. R. 1982. The Biology of the Mycobacteria (eds Ratledge, C. & Stanford, J.) (Academic, San Diego): 53

331. Raupach, B., and S. H. Kaufmann. 2001. Immune responses to intracellular bacteria. Curr Opin Immunol 13:417.

332. Ravn, P., A. Demissie, T. Eguale, H. Wondwosson, D. Lein, H. A. Amoudy, A. S. Mustafa, A. K. Jensen, A. Holm, I. Rosenkrands, F. Oftung, J. Olobo, F. von Reyn, and P. Andersen. 1999. Human T cell responses to the ESA T -6 antigen from Mycobacterium tuberculosis. J Infect Dis 179:637.

333. Raynaud, C., K. G. Papavinasasundaram, R. A. Speight, B. Springer, P. Sander, E. C. Bottger, M. J. Colston, and P. Draper. 2002. The functions of OmpATb, a pore-forming protein of Mycobacterium tuberculosis. Mol Microbiol46:19I.

334. Reid, S. D., G. Penna, and L. Adorini. 2000. The control ofT cell responses by dendritic cell subsets. Curr Opin Immuno/12:114.

335. Reiley, W. W., M. D. Calayag, S. T. Wittmer, J. L. Huntington, J. E. Pearl, J. J. Fountain, C. A. Martino, A. D. Roberts, A. M. Cooper, G. M. Winslow, and D. L. Woodland. 2008. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci US A 105:10961.

336. Reise Sousa, C. 2001. Dendritic cells as sensors of infection. Immunity 14:495.

337. Reljic, R., C. DiSano, C. Crawford, F. Dieli, S. Challacombe, and J. Ivanyi. 2005. Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice. Tuberculosis (Edinb) 85:81.

338. Rengarajan, J., B. R. Bloom, and E. J. Rubin. 2005. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Nat! Acad Sci U S A 102:8327.

339. Rescigno, M., F. Granucci, S. Citterio, M. Foti, and P. Ricciardi-Castagnoli. 1999. Coordinated events during bacteria-induced DC maturation.Immunol Today 20:200.

184

'References

340. Roberts, A. D., M.G. Sonnenberg, D. J. Ordway, S. K. Furney, P. J. Brennan, J. T. Belisle, and 1. M. Orme. 1995. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85:502.

341. Roberts, E. A., J. Chua, G. B. Kyei, and V. Deretic. 2006. Higher order Rab programming in phagolysosome biogenesis. J Cell Bio/174:923.

342. Roche, P. W., J. A. Triccas, D. T. Avery, T. Fifis, H. Billman-Jacobe, and W. J. Britton. 1994. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guerin from infection with Mycobacterium tuberculosis. J Infect Dis 170:1326.

343. Roche, P. W., N. Winter, J. A. Triccas, C. G. Feng, and W. J. Britton. 1996. Expression of Mycobacterium tuberculosis MPT64 in recombinant Myco. smegmatis: purification, immunogenicity and application to skin tests for tuberculosis. Clin Exp Immuno/1 03:226.

344. Rojas, R. E., K. N. Balaji, A. Subramanian, and W. H. Boom. 1999. Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-1 0 and transforming growth factor beta. Infect Jmmun 67:6461.

345. Rolph, M. S., B. Raupach, H. H. Kobernick, H. L. Collins, B. Perarnau, F. A. Lemonnier, and S. H. Kaufmann. 2001. MHC class !a-restricted T cells partially account for beta2-microglobulin­dependent resistance to Mycobacterium tuberculosis. Eur J Jmmunol 31:1944.

346. Rook, G. A., G. M. Bahr, and J. L. Stanford. 1981. The effect of two distinct forms of cell­mediated response to mycobacteria on the protective efficacy ofBCG. Tubercle 62:63.

347. Rook, G. A., J. Steele, S. Barnass, J. Mace, and J. L. Stanford. 1986. Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin Exp Immunol 63:105.

348. Rothfuchs, A. G., A. Bafica, C. G. Feng, J. G. Egen, D. L. Williams, G. D. Brown, and A. Sher. 2007. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J Jmmuno/179:3463.

349. Rouanet, C., A. S. Debrie, S. Lecher, and C. Locht. 2009. Subcutaneous boosting with heparin binding haemagglutinin increases BCG-induced protection against tuberculosis. Microbes Infect 11:995.

350. Roy, S., P. F. Barnes, A. Garg, S. Wu, D. Cosman, and R. Vankayalapati. 2008. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Jmmuno/180: 1729.

351. Ruoslahti, E. 1988. Structure and biology ofproteoglycans. Annu Rev Cell Bioi 4:229.

352. Russell, D. G. 2001. Mycobacterium tuberculosis: heretoday, and here tomorrow. Nature Rev. Mol. Cell Bio/2: 569.

353. Russell, D. G. 2007.Who puts the tubercle in tuberculosis? Nat Rev Micro 5: 39.

354. Russell, D. G., G. E. Purdy, R. M. Owens, K. Rohde, and R. M. Yates. 2005. Mycobacterium tuberculosis and theconcept of the '4 minute' phagosome. ASM News 71: 459.

355. Rutault, K., C. Alderman, B. M. Chain, and D. R. Katz. 1999. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Bioi Med 26:232.

356. Sahoo, N.C., K. V. Rao, and K. Natarajan. 2002. CD80 expression is induced on activated B cells following stimulation by CD86. Scand J Jmmunol 55:577.

185

References

357. Salam, N., S. Gupta, S. Sharma, S. Pahujani, A. Sinha, R. K. Saxena, and K. Natarajan. 2008. Protective immunity to Mycobacterium tuberculosis infection by chemokine and cytokine conditioned CFP-10 differentiated dendritic cells. PLoS One 3:e2869.

358. Salgame, P. 2005. Host innate and Thl responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr Opin lmmuno/17:374.

359. Sambandamurthy, V. K., S.C. Derrick, T. Hsu, B. Chen, M. H. Larsen, K. V. Jalapathy, M. Chen, J. Kim, S. A. Porcelli, J. Chan, S. L. Morris, and W. R. Jacobs, Jr. 2006. Mycobacterium tuberculosis DeltaRD 1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24:6309.

360. Samten, B., P. Ghosh, A. K. Yi, S. E. Weis, D. L. Lakey, R. Gonsky, U. Pendurthi, B. Wizel, Y. Zhang, M. Zhang, J. Gong, M. Fernandez, H. Safi, R. Vankayalapati, H. A. Young, and P. F. Barnes. 2002. Reduced expression of nuclear cyclic adenosine 5'-monophosphate response element-binding proteins and IFN-gamma promoter function in disease due to an intracellular pathogen. J lmmuno/168:3520.

361. Sander, C. R., A. A. Pathan, N. E. Beveridge, I. Poulton, A. Minassian, N. Alder, J. Van Wijgerden, A. V. Hill, F. V. Gleeson, R. J. Davies, G. Pasvol, and H. McShane. 2009. Safety and immunogenicity of a new tuberculosis vaccine, MY A85A, in Mycobacterium tuberculosis­infected individuals. Am J Respir Crit Care Med 179:724.

362. Santosuosso, M., S. McCormick, X. Zhang, A. Zganiacz, and Z. Xing. 2006. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. infect lmmun 74:4634.

363. Saunders, B. M., A. A. Frank, I. M. Orme, and A. M. Cooper. 2000. lnterleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect lmmun 68:3322.

364. Scanga, C. A., V. P. Mohan, K. Yu, H. Joseph, K. Tanaka, J. Chan, and J. L. Flynn. 2000. Depletion of CD4( +) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J Exp Med 192:347.

365. Schaible, U. E., S. Sturgill-Koszycki, P. H. Schlesinger, and D. G. Russell. 1998. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macro phages. J lmmunol 160:1290.

366. Schindler, R., J. Mancilla, S. Endres, R. Ghorbani, S. C. Clark, and C. A. Dinarello. 1990. Correlations and interactions in the production of interleukin-6 (IL-6), IL-l, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-l and TNF. Blood 75:40.

367. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 150:2920.

368. Schlesinger, L. S., T. M. Kaufman, S. lyer, S. R. Hull, and L. K. Marchiando. 1996. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J lmmuno/157:4568.

369. Schreiber, S., S. L. Perkins, S. L. Teitelbaum, J. Chappel, P. D. Stahl, and J. S. Blum. 1993. Regulation of mouse bone marrow macrophage mannose receptor expression and activation by prostaglandin E and IFN-gamma. J lmmuno/151 :4973.

370. Scott-Browne, J. P., S. Shafiani, G. Tucker-Heard, K. Ishida-Tsubota, J. D. Fontenot, A. Y. Rudensky, M. J. Bevan, and K. B. Urdahl. 2007. Expansion and function of Foxp3-expressing T

186

'References

regulatory cells during tuberculosis. J Exp Med 204:2159.

371. Scriba, T. J., B. Kalsdorf, D. A. Abrahams, F. Isaacs, J. Hofmeister, G. Black, H. Y. Hassan, R. J. Wilkinson, G. Walzl, S. J. Gelderbloem, H. Mahomed, G. D. Hussey, and W. A. Hanekom. 2008. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti­mycobacterial immune response. J Immuno/180:1962.

372. Selwyn, P. A., D. Hartel, Y. A. Lewis, E. E. Schoenbaum, S. H. Yermund, R. S. Klein, A. T. Walker, and G. H. Friedland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Eng! J Med 320:545.

373. Sendide, K., A. E. Deghmane, D. Pechkovsky, Y. Av-Gay, A. Tala!, and Z. Hmama. 2005. Mycobacterium bovis BCG attenuates surface expression of mature class II molecules through IL­l 0-dependent inhibition of cathepsin S. J Immunol 175:5324.

3 74. Serb ina, N. Y., and J. L. Flynn. 1999. Early emergence of CD8( +) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun 67:3980.

375. Shabaana, A. K., K. Kulangara, I. Semac, Y. Pare!, S. llangumaran, K. Dharmalingam, C. Chizzolini, and D. C. Hoessli. 2005. Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling. Cell Mol Life Sci 62:I79.

376. Shen, H., J. F. Miller, X. Fan, D. Kolwyck, R. Ahmed, and J. T. Harty. 1998. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell92:535.

377. Shiloh, M. U., and C. F. Nathan. 2000. Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Curr Opin Microbial 3:35.

378. Silva, M. T., M. N. Silva, and R. Appelberg. 1989. Neutrophil-macrophage cooperation in the host defence against mycobacterial infections. Microb Pathog 6:369.

379. Silva, C. L., and D. B. Lowrie. 2000. Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infect Immun 68:3269.

380. Silva, C. L., V. L. Bonato, K. M. Lima, A. A. Coelho-Castelo, L. H. Faccioli, A. Sartori, A. 0. De Souza, and S. C. Leao. 200 I. Cytotoxic T cells and mycobacteria. FEMS Microbial Lett I 97:11.

381. Singh, S. B., A. S. Davis, G. A. Taylor, and V. Deretic. 2006. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313:1438.

382. Singh, A., D. K. Crossman, D. Mai, L. Guidry, M. I. Voskuil, M. B. Renfrow, and A. J. Steyn. 2009. Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response. PLoS Pathog 5:e1000545.

383. Singhal, A., A. Jaiswal, V. K. Arora, and H. K. Prasad. 2007. Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism. Infect Immun 75:2500.

384. Sinha, A., A. Singh, Y. Satchidanandam, and K. Natarajan. 2006. Impaired generation of reactive oxygen species during differentiation of dendritic cells (DCs) by Mycobacterium tuberculosis secretory antigen (MTSA) and subsequent activation of MTSA-DCs by mycobacteria results in increased intracellular survival. J 1mmunol 177:468.

385. Soares, A. P., T. J. Scriba, S. Joseph, R. Harbacheuski, R. A. Murray, S. J. Gelderbloem, A. Hawkridge, G. D. Hussey, H. Maecker, G. Kaplan, and W. A. Hanekom. 2008. Bacillus Calmette-

187

'References

Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immuno!I80:3569.

386. Sorensen, A. L., S. Nagai, G. Houen, P. Andersen, and A. B. Andersen. 1995. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 63:I710.

387. Sousa, A. 0., R. J. Mazzaccaro, R. G. Russell, F. K. Lee, 0. C. Turner, S. Hong, L. Van Kaer, and B. R. Bloom. 2000. Relative contributions of distinct MHC class !-dependent cell populations in protection to tuberculosis infection in mice. Proc Nat! Acad Sci US A 97:4204.

388. Sporn, M. B., A. B. Roberts, L. M. Wakefield, and R. K. Assoian. 1986. Transforming growth factor-beta: biological function and chemical structure. Science 233:532.

389. Srivastava, V., M. Manchanda, S. Gupta, R. Singla, D. Behera, G. Das, and K. Natarajan. 2009. Toll-like receptor 2 and DC-SIGNRI differentially regulate suppressors of cytokine signaling I in dendritic cells during Mycobacterium tuberculosis infection. J Bioi Chern 284:25532.

390. Stamm, L. M., J. H. Morisaki, L. Y. Gao, R. L. Jeng, K. L. McDonald, R. Roth, S. Takeshita, J. Heuser, M.D. Welch, and E. J. Brown. 2003. Mycobacterium marinum escapes from phagosomes and is propelled by actin-based motility. J Exp Med 198:1361.

391. Stead, W. W. 1965. The Pathogenesis of Pulmonary Tuberculosis among Older Persons. Am Rev Respir Dis 91:811.

392. Stead, W. W. 1967. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis 95:729.

393. Steinman, R. M. 1999.Dendritic cells. In: Fundamental Immunology (William E. Paul, ed) Lippincott-Raven Publishers, PA. 547-573

394. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Ann Rev Immuno/9: 271.

395. Stenger, S. 2005. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis 64 Suppl4:iv24.

396. Stockinger, B., and M. Veldhoen. 2007. Differentiation and function of Thl7 T cells. Curr Opin Immuno/19:281.

397. StopTB Partnership Working Group on New TB Vaccines. Tuberculosis Vaccine Pipeline 2009: http :1 !www. stoptb. org/wg/new _vaccines/ assets/ documents/TB %20Vaccine%20Pipeline%2 02 00 .pdf

398. Stover, C. K., V. F. de Ia Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, and eta!. 1991. New use of BCG for recombinant vaccines. Nature 351:456.

399. Strong, M., M. R. Sawaya, S. Wang, M. Phillips, D. Cascio, and D. Eisenberg. 2006. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Nat! Acad Sci US A 103:8060.

400. Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, and D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-A TPase. Science 263:678.

188

'References

401. Styblo, K. 1980. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 20:1.

402. Sun, J., A. E. Deghmane, H. Soualhine, T. Hong, C. Bucci, A. Solodkin, and Z. Hmama. 2007. Mycobacterium bovis BCG disrupts the interaction of Rab7 with RILP contributing to inhibition of phagosome maturation. J Leukoc Biol82:1437.

403. Sun, Q., C. T. Kong, F. P. Huang, and L. C. Chan. 2008. Aberrant dendritic cell differentiation initiated by the Mll-Een fusion gene does not require leukemic transformation. J Leukoc Bioi 83:173.

404. Sun, R., Y. A. Skeiky, A. Izzo, V. Dheenadhayalan, Z. Imam, E. Penn, K. Stagliano, S. Haddock, S. Mueller, J. Fulkerson, C. Scanga, A. Grover, S. C. Derrick, S. Morris, D. M. Hone, M. A. Horwitz, S. H. Kaufmann, and J. C. Sadoff. 2009. Novel recombinant BCG expressing perfringolysin 0 and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine 27:4412.

405. Tailleux, L., 0. Schwartz, J. L. Herrmann, E. Pivert, M. Jackson, A. Amara, L. Legres, D. Dreher, L. P. Nicod, J. C. Gluckman, P. H. Lagrange, B. Gicquel, and 0. Neyrolles. 2003. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197:121.

406. Tailleux, L., N. Pham-Thi, A. Bergeron-Lafaurie, J. L. Herrmann, P. Charles, 0. Schwartz, P. Scheinmann, P. H. Lagrange, J. de Blic, A. Tazi, B. Gicquel, and 0. Neyrolles. 2005. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis. PLoS Med 2:e381.

407. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu Rev Jmmuno/21:335.

408. Tan, T., W. L. Lee, D. C. Alexander, S. Grinstein, and J. Liu. 2006. The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation. Cell Microbial 8:1417.

409. Tan, B. H., C. Meinken, M. Bastian, H. Bruns, A. Legaspi, M. T. Ochoa, S. R. Krutzik, B. R. Bloom, T. Ganz, R. L. Modlin, and S. Stenger. 2006. Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J lmmunol 177:1864.

410. Tanghe, A., S. D'Souza, V. Rosseels, 0. Denis, T. H. Ottenhoff, W. Dalemans, C. Wheeler, and K. Huygen. 2001. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.Jnfect lmmun 69:3041.

411. Tascon, R. E., C. S. Soares, S. Ragno, E. Stavropoulos, E. M. Hirst, and M. J. Colston. 2000. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice. Immunology 99:473.

412. Taylor, J. L., D. J. Ordway, J. Troudt, M. Gonzalez-Juarrero, R. J. Basaraba, and l. M. Orme. 2005. Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis­infected mice vaccinated therapeutically with hsp65 DNA. infect lmmun 73:5189.

413. Teitelbaum, R., M. Cammer, M. L. Maitland, N. E. Freitag, J. Condeelis, and B. R. Bloom. 1999. Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc Nat/ Acad Sci US A 96:15190.

414. Thurnher, M., R. Ramoner, G. Gastl, C. Radmayr, G. Bock, M. Herold, H. Klocker, and G. Bartsch. 1997. Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells.lnt J Cancer 70:128.

415. Tian, T., J. Woodworth, M. Skold, and S. M. Behar. 2005. In vivo depletion of CDllc+ cells

189

'References

delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J Immuno/175:3268.

416. Tobian, A. A., N. S. Potter, L. Ramachandra, R. K. Pai, M. Convery, W. H. Boom, and C. V. Harding. 2003. Alternate class 1 MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J Immuno/171:1413.

417. Toossi, Z., P. Gogate, H. Shiratsuchi, T. Young, and J. J. Ellner. 1995. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immuno/154:465.

418. Toossi, Z., and J. J. Ellner. 1998. The role ofTGF beta in the pathogenesis ofhuman tuberculosis. Clin 1mmunol Immunopatho/87:107.

419. Trunz, B. B., P. Fine, and C. Dye. 2006. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost­effectiveness. Lancet 367:1173.

420. Tsai, M. C., S. Chakravarty, G. Zhu, J. Xu, K. Tanaka, C. Koch, J. Tufariello, J. Flynn, and J. Chan. 2006. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbio/8:218.

421. Tsenova, L., R. Harbacheuski, N. Sung, E. Ellison, D. Fallows, and G. Kaplan. 2007. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 25:5126.

422. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1 ). 1nt J Cancer 26:171.

423. Tsuji, S., M. Matsumoto, 0. Takeuchi, S. Akira, I. Azuma, A. Hayashi, K. Toyoshima, and T. Seya. 2000. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect Immun 68:6883.

424. Tsukada, J., A. Ozaki, T. Hanada, T. Chinen, R. Abe, A. Yoshimura, and M. Kubo. 2005. The role of suppressor of cytokine signaling 1 as a negative regulator for aberrant expansion of CD8alpha+ dendritic cell subset. Int Immuno/17: 1167.

425. Tullius, M. Y., G. Harth, S. Maslesa-Galic, B. J. Dillon, and M.A. Horwitz. 2008. A Replication­Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. Infect Immun 76:5200.

426. Tundup, S., Y. Akhter, D. Thiagarajan, and S. E. Hasnain. 2006. Clusters of PE and PPE genes of Mycobacterium tuberculosis are organized in operons: evidence that PE Rv243lc is co-transcribed with PPE Rv2430c and their gene products interact with each other. FEES Lett 580:1285.

427. Turner, J., C. D. D'Souza, J. E. Pearl, P. Marietta, M. Noel, A. A. Frank, R. Appelberg, I. M. Orme, and A. M. Cooper. 2001. CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am J Respir Cell Mol Bioi 24:203.

428. Turner, J., M. Gonzalez-Juarrero, D. L. Ellis, R. J. Basaraba, A. Kipnis, I. M. Orme, and A. M. Cooper. 2002. ln vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immuno/169:6343.

429. Turville, S. G., J. Arthos, K. M. Donald, G. Lynch, H. Naif, G. Clark, D. Hart, and A. L. Cunningham. 2001. HIV gpl20 receptors on human dendritic cells. Blood 98:2482.

190

References

430. Ulrichs, T., M. E. Munk, H. Mollenkopf, S. Behr-Perst, R. Colangeli, M. L. Gennaro, and S. H. Kaufmann. 1998. Differential T cell responses to Mycobacterium tuberculosis ESA T6 in tuberculosis patients and healthy donors. Eur J Immunol 28:3949.

431. Ulrichs, T., G. A. Kosmiadi, S. Jorg, L. Pradl, M. Titukhina, V. Mishenko, N. Gushina, and S. H. Kaufmann. 2005. Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma. J Infect Dis I 92:89.

432. Ulrichs, T., and S. H. Kaufmann. 2006. New insights into the function of granulomas in human tuberculosis. J Patho/208:261.

433. Umemura, M., A. Yahagi, S. Hamada, M.D. Begum, H. Watanabe, K. Kawakami, T. Suda, K. Sudo, S. Nakae, Y. Iwakura, and G. Matsuzaki. 2007. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immuno/178:3786.

434. van Creve!, R., T. H. Ottenhoff, and J. W. van der Meer. 2002. Innate immunity to Mycobacterium tuberculosis. Clin Microbial Rev 15:294.

435. van der Wei, N., D. Hava, D. Houben, D. Fluitsma, M. van Zon, J. Pierson, M. Brenner, and P. J. Peters. 2007. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cel/129: 1287.

436. van Kooyk, Y., and T. B. Geijtenbeek. 2003. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3:697.

437. van Pinxteren, L. A., J. P. Cassidy, B. H. Smedegaard, E. M. Agger, and P. Andersen. 2000. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 30:3689.

438. van Pinxteren, L. A., P. Ravn, E. M. Agger, J. Pollock, and P. Andersen. 2000. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFPIO. Clin Diagn Lab Immunol 7:155.

439. Vandal, 0. H., L. M. Pierini, D. Schnappinger, C. F. Nathan, and S. Ehrt. 2008. A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat Med 14:849.

440. Vandal, 0. H., C. F. Nathan, and S. Ehrt. 2009. Acid resistance in Mycobacterium tuberculosis. J Bacterio/191:4714.

441. Vandal, 0. H., J. A. Roberts, T. Odaira, D. Schnappinger, C. F. Nathan, and S. Ehrt. 2009. Acid­susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. J Bacterio/191:625.

442. Vankayalapati, R., B. Wizel, S. E. Weis, H. Safi, D. L. Lakey, 0. Mandelboim, B. Samten, A. Porgador, and P. F. Barnes. 2002. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immuno/168:3451.

443. Vankayalapati, R., A. Garg, A. Porgador, D. E. Griffith, P. Klucar, H. Safi, W. M. Girard, D. Cosman, T. Spies, and P. F. Barnes. 2005. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 175:4611.

444. Vaquero, E. C., M. Edderkaoui, S. J. Pando!, I. Gukovsky, and A. S. Gukovskaya. 2004. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Bioi Chem 279:34643.

191

'References

445. Vergne, I., J. Chua, H. H. Lee, M. Lucas, J. Belisle, and V. Deretic. 2005. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc Nat/ Acad Sci US A 102:4033.

446. Verhasselt, V., M. Goldman, and F. Willems. 1998. Oxidative stress up-regulates IL-8 and TNF­alpha synthesis by human dendritic cells. Eur J lmmunol 28:3886.

447. Verreck, F. A., T. de Boer, D. M. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. Ottenhoff. 2004. Human IL-23-producing type I macrophages promote but IL-l 0-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Nat/ A cad Sci US A 101:4560.

448. Via, L. E., D. Deretic, R. J. Ulmer, N. S. Hibler, L. A. Huber, and V. Deretic. 1997. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J Bioi Chern 272:13326.

449. Via, L. E., R. A. Fratti, M. McFalone, E. Pagan-Ramos, D. Deretic, and V. Deretic. 1998. Effects of cytokines on mycobacterial phagosome maturation. J Cell Sci Ill ( Pt 7):897.

450. Vieira, 0. V., R. E. Harrison, C. C. Scott, H. Stenmark, D. Alexander, J. Liu, J. Gruenberg, A. D. Schreiber, and S. Grinstein. 2004. Acquisition of Hrs, an essential component of phagosomal maturation, is impaired by mycobacteria. Mol Cell Bioi 24:4593.

451. Vilaplana, C., E. Montane, S. Pinto, A. M. Barriocanal, G. Domenech, F. Torres, P. J. Cardona, and J. Costa. Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI. Vaccine 28:1106.

452. Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R. A. Kastelein, C. Saris, and C. A. Hunter. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645.

453. Villarino, A. V., E. Huang, and C. A. Hunter. 2004. Understanding the pro- and anti-inflammatory properties ofiL-27. J lmmunol 17 3:715.

454. Von Eschen, K., R. Morrison, M. Braun, 0. Ofori-Anyinam, E. De Kock, P. Pavithran, M. Koutsoukos, P. Moris, D. Cain, M. C. Dubois, J. Cohen, and W. R. Ballou. 2009. The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans. Hum Vaccin 5:475.

455. von Reyn, C. F., and J. M. Vuola. 2002. New vaccines for the prevention of tuberculosis. Clin Infect Dis 35:465.

456. von Reyn, C. F., L. Mtei, R. Arbeit, R. Waddell, B. Cole, T. Mackenzie, M. Matee, M. Bakari, S. Tvaroha, L. V. Adams, C. R. Horsburgh, K. Pallangyo. 2010. Prevention of tuberculosis in BCG­primed, HIV-infected adults boosted with an inactivated whole cell mycobacterial vaccine. Aids 2010, in press, doi:l0.1097/QAD.Ob013e3283350flb.

457. Vorderrneier, H. M., N. Venkataprasad, D.P. Harris, and J. Ivanyi. 1996. Increase of tuberculous infection in the organs of B cell-deficient mice. Clin Exp Jmmuno/106:312.

458. Walburger, A., A. Koul, G. Ferrari, L. Nguyen, C. Prescianotto-Baschong, K. Huygen, B. Klebl, C. Thompson, G. Bacher, and J. Pieters. 2004. Protein kinase G from pathogenic mycobacteria promotes survival within macrophages. Science 304:1800.

459. Wang, C. H., C. Y. Liu, H. C. Lin, C. T. Yu, K. F. Chung, and H. P. Kuo. 1998. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J II :809.

192

References

460. Wang, J., J. Wakeham, R. Harkness, and Z. Xing. 1999. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 103:1023.

461. Wang, Y., H. M. Curry, B. S. Zwilling, and W. P. Lafuse. 2005. Mycobacteria inhibition of IFN­gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J Immunoll74:5687.

462. Weikert, L. F., K. Edwards, Z. C. Chroneos, C. Hager, L. Hoffman, and V. L. Shepherd. 1997. SP­A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor. Am J Physiol 272:L989.

463. Welin, A., M. E. Winberg, H. Abdalla, E. Sarndahl, B. Rasmusson, 0. Stendahl, and M. Lerm. 2008. Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block. Infect Immun 76:2882.

464. Werling, D., J. C. Hope, C. J. Howard, and T. W. Jungi. 2004. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists. Immunology Ill :41.

465. Wheeler, P. R. and C. Ratledge. 1994. In Tuberculosis: Pathogenesis, Protection, and Control ( ed. Bloom, B. R.) (Am. Soc. Microbiol., Washington DC,) 353.

466. WHO: World Health Organization Tuberculosis at http:/lwwwwhoint/tb/en/2008

467. Wieland, C. W., E. A. Koppel, J. den Dunnen, S. Florquin, A. N. McKenzie, Y. van Kooyk, T. van der Poll, and T. B. Geijtenbeek. 2007. Mice lacking SIGNRI have stronger T helper I responses to Mycobacterium tuberculosis. Microbes Infect 9:134.

468. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbial Rev 56:648.

469. Winau, F., S. Weber, S. Sad, J. de Diego, S. L. Hoops, B. Breiden, K. Sandhoff, V. Brinkmann, S. H. Kaufmann, and U. E. Schaible. 2006. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 24:105.

470. Winkler, S., M. Necek, H. Winkler, A. A. Adegnika, T. Perkmann, M. Rarnharter, and P. G. Kremsner. 2005. Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa. Microbes Infect 7:1161.

471. Winslow, G. M., A. D. Roberts, M. A. Blackman, and D. L. Woodland. 2003. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J Immunoll70:2046.

472. Wolf, A. J., B. Linas, G. J. Trevejo-Nunez, E. Kincaid, T. Tamura, K. Takatsu, and J.D. Ernst. 2007. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunoll79:2509.

473. Wolf, A. J., L. Desvignes, B. Linas, N. Banaiee, T. Tamura, K. Takatsu, and J.D. Ernst. 2008. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med 205:105.

474. World Health Organization. 2008, 2009. Global tuberculosis control - surveillance, planning, financing. Geneva, Switzerland.

475. Wu, C. H., J. J. Tsai-Wu, Y. T. Huang, C. Y. Lin, G. G. Lioua, and F. J. Lee. 1998. Identification and subcellular localization of a novel Cu,Zn superoxide dismutase of Mycobacterium tuberculosis. FEBS Lett 439:192.

193

References

476. Yanagisawa, S., M. Koike, A. Kariyone, S. Nagai, and K. Takatsu. 1997. Mapping ofV beta 11+ helper T cell epitopes on mycobacterial antigen in mouse primed with Mycobacterium tuberculosis. Int Immuno/9:227.

477. Yang, C. S., J. S. Lee, C. H. Song, G. M. Hur, S. J. Lee, S. Tanaka, S. Akira, T. H. Paik, and E. K. Jo. 2007. Protein kinase C zeta plays an essential role for Mycobacterium tuberculosis-induced extracellular signal-regulated kinase 112 activation in monocytes/macrophages via Toll-like receptor 2. Cell Microbial 9:382.

478. Young, D. B., M. D. Perkins, K. Duncan, and C. E. Barry, 3rd. 2008. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest I I 8:1255.

479. Young, D. 2009. Animal models oftuberculosis. EurJ Immuno/39:2011.

480. Yu, W., E. Soprana, G. Cosentino, M. Volta, H. S. Lichenstein, G. Viale, and D. Vercelli. 1998. Soluble CD 14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. J Immuno/161:4244.

481. Yu, C. R., R. M. Mahdi, S. Ebong, B. P. Vistica, J. Chen, Y. Guo, I. Gery, and C. E. Egwuagu. 2004. Cell proliferation and STA T6 pathways are negatively regulated in T cells by ST A T1 and suppressors of cytokine signaling. J Immuno/173:737.

482. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, and W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J Clin Invest 91:2076.

483. Zimmerli, S., S. Edwards, and J.D. Ernst. 1996. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am J Respir Cell Mol B iol 15: 7 60.

194